Igf-1 Deficiency
📧 Sign up to get email alerts when something new happens for Igf-1 Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-03FDA Approved: INCRELEX — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for INCRELEX (mecasermin) submitted by Ipsen Biopharmaceuticals, Inc.